CEO Letters - Emmaus Medical, Inc.

CEO Letter February 07, 2022February 07, 2022

Emmaus Life Sciences is devoted to developing new novel therapeutics for patients suffering from Sickle Cell Disease. African Americans disproportionately suffer from this disease, and as we celebrate Black History Month, we are encouraged by the new attention that has been focused on our community. The coalitions we have formed through our community partners and the medical community continue to drive solutions to meet this unmet medical need.

CEO Letter, June 12, 2020June 12, 2020

We stand in solidarity with all those who have been unfairly targeted by racial injustice and racism in our world today. We march with those who strive towards a better future, and as the late Martin Luther King Jr. once said, we have this hope that we can create a world in which people are not judged by the color of their skin but the content of their character